Print

New ANDA Cases

Case Name

Date Filed

Judge

Drug

Patent
No(s).

Purdue Pharma. Products L.P. v. Dr. Reddy’s Labs., Inc., 13-2067 (D.N.J.)

Apr. 2, 2013

Hon. Jose L. Linares

Intermezzo® (zolpidem tartrate sublingual tablet)

7,682,628

8,242,131

8,252,809

Novartis Pharma. Corp. v. Noven Pharma., Inc., 13-0527 (D. Del.)

Apr. 3, 2013

Hon. Richard G. Andrews

Exelon® Patch (rivastigmine transdermal system or extended-release film)

6,316,023

6,335,031

Novartis Pharma. Corp. v. Accord Healthcare Inc., 13-2379 (D.N.J.)

Apr. 12, 2013

Hon. Susan D. Wigenton

Zometa® (zoledronic acid injection)

8,324,189

Braintree Labs., Inc. v. Gator Pharma., Inc., 13-0389 (M.D. Fla.)

Apr. 15, 2013

Hon. Timothy J. Corrigan

Suprep® Bowel Prep Kit (sodium sulfate / potassium sulfate / magnesium sulfate)

6,946,149

Braintree Labs., Inc. v. Gator Pharma., Inc., 13-1975 (E.D. Pa.)

Apr. 15, 2013

Hon. Paul S. Diamond

Suprep® Bowel Prep Kit (sodium sulfate / potassium sulfate / magnesium sulfate)

6,946,149

Shionogi & Co., Ltd. v. Hospira, Inc., 13-2400 (D.N.J.)

Apr. 15, 2013

Hon. Freda L. Wolfson

Doribax® (doripenem for injection)

8,247,402

Helsinn Healthcare S.A. v. Aurobindo Pharma Ltd., 13-0688 (D. Del.)

Apr. 16, 2013

Hon. Sherry R. Fallon

Aloxi® (palonosetron hydrochloride intravenous solution)

7,947,724

7,947,725

7,960,424

Pfizer Inc. v. Inventia Healthcare Private Ltd., 13-2986 (N.D. Ill.)

Apr. 19, 2013

Hon. Edmond E. Chang

Detrol® LA (tolterodine tartrate extended-release capsules)

6,630,162

6,770,295

Par Pharma., Inc. v. Takeda Pharma. Co., Ltd., 13-1927 (N.D. Ca.)

Apr. 26, 2013

Hon. Lucy H. Koh

Dexilant® (dexlansoprazole capsules)

8,105,626

8,173,158

Acura Pharma., Inc. v. Ranbaxy Inc., 13-0750 (D. Del.)

Apr. 29, 2013

Hon. Richard G. Andrews

Oxecta® (oxycodone hydrochloride tablets)

7,510,726

The Medicines Co. v. Apotex Inc., 13-2801 (D.N.J.)

May 1, 2013

Hon. Peter G. Sheridan

Angiomax® (bivalirudin for injection)

7,582,727

7,598,343

AstraZeneca AB v. Watson Labs., Inc.—Florida, 13-13-3038 (D.N.J.)

May 10, 2013

Hon. Joel A. Pisano

Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)

5,714,504

6,369,085

6,875,872

7,411,070

7,745,466

Purdue Pharma L.P. v. Impax Labs., Inc., 13-3188 (S.D.N.Y.)

May 10, 2013

Hon. Sidney H. Stein

OxyContin® (oxycodone hydrochloride)

8,337,888

Bayer Pharma AG v. Par Pharma., Inc., 13-0845 (D. Del.)

May 14, 2013

Hon. Gregory M. Sleet

Staxyn® (vardenafil hydrochloride orally disintegrating tablets)

6,362,178

7,696,206

Senju Pharma. Co., Ltd. v. Strides, Inc., 13-0851 (D. Del.)

May 15, 2013

Hon. Sue L. Robinson

Zymar® / Zymaxid® (gatifloxacin ophthalmic solution)

6,333,045

Abbvie, Inc. v. Hetero USA Inc., 13-0852 (D. Del.)

May 15, 2013

Hon. Richard G. Andrews

Norvir® (ritonavir tablets)

7,148,359

7,364,752

8,268,349

6,037,157

6,703,403

Endo Pharma. Inc. v. Par Pharma. Co., Inc., 13-3284 (S.D.N.Y.)

May 15, 2013

Hon. Thomas P. Griesa

Opana® ER CRF (oxymorphone hydrochloride extended-release tablets)

7,851,482

8,309,122

8,329,216

Endo Pharma. Inc. v. Teva Pharma. USA Inc., 13-3285 (S.D.N.Y.)

May 15, 2013

Hon. Thomas P. Griesa

Opana® ER CRF (oxymorphone hydrochloride extended-release tablets)

7,851,482

8,309,122

8,329,216

Endo Pharma. Inc. v. Mallinckrodt, LLC, 13-3286 (S.D.N.Y.)

May 15, 2013

Hon. Thomas P. Griesa

Opana® ER CRF (oxymorphone hydrochloride extended-release tablets)

7,851,482

8,309,122

8,329,216

Endo Pharma. Inc. v. Sandoz, Inc., 13-3287 (S.D.N.Y.)

May 15, 2013

Hon. Thomas P. Griesa

Opana® ER CRF (oxymorphone hydrochloride extended-release tablets)

7,851,482

8,309,122

8,329,216

Endo Pharma. Inc. v. Roxane Labs., Inc., 13-3288 (S.D.N.Y.)

May 15, 2013

Hon. Thomas P. Griesa

Opana® ER CRF (oxymorphone hydrochloride extended-release tablets)

7,851,482

8,309,122

8,329,216

Purdue Pharma L.P. v. Amneal Pharma., LLC, 13-3372 (S.D.N.Y.)

May 17, 2013

Hon. Sidney H. Stein

OxyContin® (oxycodone hydrochloride)

8,337,888

Purdue Pharma L.P. v. Par Pharma., Inc., 13-3374 (S.D.N.Y.)

May 17, 2013

Hon. Sidney H. Stein

OxyContin® (oxycodone hydrochloride)

8,337,888

8,309,060

Fresenius Kabi USA, LLC v. Dr. Reddy’s Labs., Ltd., 13-0925 (D. Del.)

May 23, 2013

Hon. Sue L. Robinson

Diprivan® (propofol 1% injectable emulsion)

5,714,520

5,731,355

5,731,356

5,908,869

Eli Lilly and Co. v. Perrigo Co., 13-0851 (S.D. Ind.)

May 24, 2013

Hon. Sarah Evans Barker

Axiron® (testosterone metered transdermal solution)

8,435,944

8,419,307

8,177,449

Takeda Pharma. Co., Ltd. v. Impax Labs., Inc., 13-2416 (N.D. Cal.)

May 29, 2013

Hon. Elizabeth D. Laporte

Dexilant® (dexlansoprazole delayed-release capsules)

8,173,158

Takeda Pharma. Co., Ltd. v. Sandoz Inc., 13-2418 (N.D. Cal.)

May 29, 2013

Hon. Donna M. Ryu

Dexilant® (dexlansoprazole delayed-release capsules)

8,173,158

Takeda Pharma. Co., Ltd. v. TWI Pharma. Inc., 13-2420 (N.D. Cal.)

May 29, 2013

Hon. Laurel Beeler

Dexilant® (dexlansoprazole delayed-release capsules)

8,173,158

Avanir Pharma. Inc. v. Sandoz, Inc., 13-0961 (D. Del.)

May 30, 2013

Hon. Leonard P. Stark

Nuedexta® (dextromethorphan hydrobromide / quinidine sulfate capsules)

7,659,282

8,227,484

RE38,115

Merck & CIE v. Watson Labs., Inc., 13-0978 (D. Del.)

June 4, 2013

Hon. Richard G. Andrews

Safyral® (drospirenone / ethinyl estradiol / levomefolate calcium tablets and levomefolate calcium tablets)

6,441,168

Pfizer Inc. v. Dr. Reddy’s Labs., Ltd., 13-0989 (D. Del.)

June 4, 2013

Hon. Sue L. Robinson

Pristiq® (O-desmethylvenlafaxine succinate extended-release tablets)

6,673,838

8,269,040

Merck & CIE v. Watson Labs., Inc., 13-0990 (D. Nev.)

June 4, 2013

Hon. Andrew P. Gordon

Safyral® (drospirenone / ethinyl estradiol / levomefolate calcium tablets and levomefolate calcium tablets)

6,441,168

Abbvie, Inc. v. Dr. Reddy’s Labs. Ltd., 13-1012 (D. Del.)

June 5, 2013

Hon. Gregory M. Sleet

Zemplar® (paricalcitol for injection)

6,136,799

6,361,758

5,597,815

Fresenius Kabi USA, LLC v. Watson Labs., Inc., 13-1015 (D. Del.)

June 6, 2013

Hon. Sue L. Robinson

Diprivan® (propofol 1% injectable emulsion)

5,714,520

5,731,355

5,731,356

5,908,869

Sun Pharma Global FZE v. Novartis Pharma. Corp., 13-3542 (D.N.J.)

June 7, 2013

Hon. Dennis M. Cavanaugh

Gleevac® (imatinib mesylate tablets)

6,894,051

Abbvie, Inc. v. Mylan Pharma., Inc., 13-1072 (D. Del.)

June 14, 2013

Hon. Richard G. Andrews

Norvir® (ritonavir soft gelatin capsule)

6,232,333

7,141,593

7,432,294

Insite Vision Inc. v. Mylan Pharma. Inc., 13-3720 (D.N.J.)

June 14, 2013

Hon. Mary L. Cooper

AzaSite® (azithromycin ophthalmic solution)

6,861,411

6,239,113

6,569,443

7,056,893

Senju Pharma. Co., Ltd. v. Apotex Inc., 13-4132 (S.D.N.Y.)

June 14, 2013

Hon. Paul A. Crotty

Istalol® (timolol maleate ophthalmic solution)

6,335,335

Accord Healthcare, Inc. v. Eli Lilly and Co., IPR2013-00356 (PTAB)

June 14, 2013

N/A

Alimta® (pemetrexed for injection)

7,772,209

Kissei Pharma. Co., Ltd. v. Hetero USA Inc., 13-1091 (D. Del.)

June 17, 2013

Hon. Leonard P. Stark

Rapaflo® (silodosin capsules)

5,387,603

Kissei Pharma. Co., Ltd. v. Sandoz Inc., 13-1092 (D. Del.)

June 17, 2013

Hon. Leonard P. Stark

Rapaflo® (silodosin capsules)

5,387,603

Alza Corp. v. Par Pharma., Inc., 13-1104 (D. Del.)

June 19, 2013

Hon. Richard G. Andrews

Concerta® (methylphenidate hydrochloride)

8,163,798

Amneal Pharma., LLC v. Supernus Pharma, LLC, IPR2013-00368 (PTAB)

June 20, 2013

N/A

Oracea® (doxycycline)

8,206,740

Amneal Pharma., LLC v. Supernus Pharma, LLC, IPR2013-00371 (PTAB)

June 20, 2013

N/A

Oracea® (doxycycline)

8,394,405

Amneal Pharma., LLC v. Supernus Pharma, LLC, IPR2013-00372 (PTAB)

June 20, 2013

N/A

Oracea® (doxycycline)

8,394,406

Pfizer Inc. v. Alkem Labs., Ltd., 13-1110 (D. Del.)

June 21, 2013

Hon. Gregory M. Sleet

Toviaz® (fesoterodine fumarate extended-release tablets)

6,858,650

7,384,980

7,855,230

7,985,772

8,338,478

Pfizer Inc. v. Sandoz, Inc., 13-1111 (D. Del.)

June 21, 2013

Hon. Gregory M. Sleet

Toviaz® (fesoterodine fumarate extended-release tablets)

6,858,650

7,384,980

7,855,230

7,985,772

8,338,478

Par Pharma., Inc. v. Breckenridge Pharma., Inc., 13-1114 (D. Del.)

June 21, 2013

Hon. Sue L. Robinson

Megace® ES (megestrol acetate oral suspension)

6,592,903

7,101,576

Endo Pharma. Inc. v. Ranbaxy Labs. Ltd., 13-4343 (S.D.N.Y.)

June 21, 2013

Unassigned

Opana® ER CRF (oxymorphone hydrochloride extended-release tablets)

7,851,482

8,309,122

8,329,216

Pfizer Inc. v. Alkem Labs., Ltd., 13-4628 (N.D. Ill.)

June 24, 2013

Hon. Joan B. Gottschall

Toviaz® (fesoterodine fumarate extended-release tablets)

6,858,650

7,384,980

7,855,230

7,985,772

8,338,478

Janssen Products, L.P. v. Lupin Ltd., 13-3891 (D.N.J.)

June 24, 2013

Hon. William H. Walls

Prezista® (darunavir tablets)

7,700,645

7,126,015

7,595,408

Alza Corp. v. Osmotica Kereskedelmi Es Szolgaltato Kft, 13-1126 (D. Del.)

June 24, 2013

Hon. Richard G. Andrews

Concerta® (methylphenidate hydrochloride)

8,163,798

Alpex Pharma, S.A. v. Zydus Pharma. USA, Inc., 13-1143 (D. Del.)

June 26, 2013

Hon. Sue L. Robinson

Suprenza® (phentermine hydrochloride tablets)

6,149,938

Alza Corp. v. Osmotica Kereskedelmi Es Szolgaltato Kft

June 26, 2013

Hon. Elaine E. Bucklo

Concerta® (methylphenidate hydrochloride)

8,163,798

Par Pharma., Inc. v. Breckenridge Pharma., Inc., 13-4000 (D.N.J.)

June 27, 2013

Hon. Kevin McNulty

Megace® ES (megestrol acetate oral suspension)

6,592,903

7,101,576

Merck, Sharp & Dohme Corp. v. Cipla USA, Inc., 13-4017 (D.N.J.)

June 27, 2013

Hon. Jerome B. Simandle

Sustiva® (efavirenz tablets)

6,639,071

6,939,964

U.S. Dept. of Health and Human Services v. Lupin Ltd., 13-4039 (D.N.J.)

June 27, 2013

Hon. William H. Walls

Prezista® (darunavir tablets)

7,470,506

UCB Inc. v. Zydus Pharma. (USA), Inc., 13-4021 (D.N.J.)

June 28, 2013

Hon. Michael A. Shipp

Vimpat® (lacosamide tablets)

RE38,551

AstraZeneca AB v. Mylan Pharma., 13-4022 (D.N.J.)

June 28, 2013

Hon. Joel A. Pisano

Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)

5,714,504

6,369,085

6,875,872

7,411,070

7,745,466

5,948,789

UCB Inc. v. Teva Pharma. USA, Inc., 13-1148 (D. Del.)

June 28, 2013

Hon. Leonard P. Stark

Vimpat® (lacosamide tablets)

RE38,551

Pfizer Inc. v. Lupin Ltd., 13-1153 (D. Del.)

June 28, 2013

Hon. Gregory M. Sleet

Toviaz® (fesoterodine fumarate extended-release tablets)

6,858,650

7,384,980

7,855,230

7,985,772

8,338,478

Pfizer Inc. v. Zydus Pharma. (USA), Inc., 13-1154 (D. Del.)

June 28, 2013

Hon. Gregory M. Sleet

Toviaz® (fesoterodine fumarate extended-release tablets)

6,858,650

7,384,980

7,855,230

7,985,772

8,338,478

Pfizer Inc. v. Accord Healthcare Inc., USA, 13-1155 (D. Del.)

June 28, 2013

Hon. Gregory M. Sleet

Toviaz® (fesoterodine fumarate extended-release tablets)

6,858,650

7,384,980

7,855,230

7,985,772

8,338,478

Pfizer Inc. v. Amerigan Pharma., Inc., 13-1156 (D. Del.)

June 28, 2013

Hon. Gregory M. Sleet

Toviaz® (fesoterodine fumarate extended-release tablets)

6,858,650

7,384,980

7,855,230

7,985,772

8,338,478

Pfizer Inc. v. Amneal Pharma., LLC, 13-1157 (D. Del.)

June 28, 2013

Hon. Gregory M. Sleet

Toviaz® (fesoterodine fumarate extended-release tablets)

6,858,650

7,384,980

7,855,230

7,985,772

8,338,478

Pfizer Inc. v. Impax Labs., Inc., 13-1158 (D. Del.)

June 28, 2013

Hon. Gregory M. Sleet

Toviaz® (fesoterodine fumarate extended-release tablets)

6,858,650

7,384,980

7,855,230

7,985,772

8,338,478

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.